Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma

Advances in cancer research(2022)10.1016/bs.acr.2022.02.003Source: DataRank Database

YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma is a research paper published in Advances in cancer research (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: greenTopics (19)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Minwook Kim ORCID,Laura Molina ORCID,Alphonse E. Sirica ORCID,Satdarshan P. Monga ORCID,Sungjin Ko ORCID

Live enrichment

PubMed:35961703 PMC:PMC9972177

National Institutes of Health

Grant: 1P30DK120531

National Institutes of Health

Grant: 1R01CA258449

National Institutes of Health

Grant: PF 2019-05

National Institutes of Health

Grant: R01CA204586

National Institutes of Health

Grant: R01CA250227

National Institutes of Health

Grant: R01CA251155

NCI NIH HHS

Grant: R01 CA258449

NIBIB NIH HHS

Grant: T32 EB001026

NIDDK NIH HHS

Grant: P30 DK120531

Pittsburgh Liver Research Center, University of Pittsburgh

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9972177

publisherhttps://api.elsevier.com/content/article/PII:S0065230X2200029X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0065230X2200029X?httpAccept=text/plain

MeSH Terms

Bile Ducts, IntrahepaticHumansCholangiocarcinomaBile Duct NeoplasmsAdaptor Proteins, Signal TransducingTumor MicroenvironmentHippo Signaling PathwayYAP-Signaling Proteins

Keywords

Stem cellHepatocyteCholangiocarcinomaProgenitorTransdifferentiationtumor immunologyBile Duct TumorsTumor MetabolismTazYap1Hippo Signaling

YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma

FAIR Checklist

Authors (5)

Funding (10 grants)

Open Access

Topics

Annotations (Europe PMC)